Baxter Healthcare recalls Cefazolin injection bags with particulate matter. Affected units contain lot # LD175708, expiring Feb 2027. Consumers should contact Baxter for details.
“Baxter recalls Cefazolin injection: Particulate matter risk.” GovInfoNow, updated September 14, 2026. https://govinfonow.com/recall/692904-baxter-recalls-cefazolin-injection-particulate-matter-risk. Based on FDA recall #D-0787-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0787-2026%22&limit=1).
Baxter Healthcare Corporation voluntarily recalled Cefazolin in Dextrose, Injection, USP, 2g / 100mL single-dose infusion bags due to the presence of particulate matter, the FDA said on July 24, 2026. The recall affects 19,032 units distributed nationwide.
How to tell if you have it
Brand: Baxter
Product: Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container
NDC: 0338-3508-41
Lot #: LD175708
Expiration Date: 14-Feb-2027
The hazard
The recall is due to the presence of particulate matter in the product. The FDA classified this as a Class I recall, indicating a high risk of adverse health consequences.
Context
GovInfoNow's records show Baxter Healthcare Corporation has 187 other recalls on record since September 2, 2015. Other recent recalls by the brand include PRO+ MRS SURFACE FOR VERSACARE (August 18, 2026), 0.9% Sodium Chloride Injection (August 17, 2026), and Dextrose 2000mL Bags (August 17, 2026). Other recent recalls of similar products include American Regent Nitroglycerin Injection (July 24, 2026), American Regent Papaverine HCl Injection (July 24, 2026), and GE Healthcare Omnipaque Injection (March 24, 2026).
How to tell if you have this one
Check for the lot number LD175708 on the bag. The product expires February 2027. This is a single-dose injection bag for medical use only.
Brand
Baxter
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number LD175708 and expiration date of February 2027 on the bag.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 26 days after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class I
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0787-2026 (July 24, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0787-2026 to see it in context.
Plain-language summary written by qwen3:4b on September 14, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.